Blepharitis
4 competing products in clinical development for Blepharitis.
Pipeline by Phase
Phase 2/31
Phase 33
All Products (4)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| ISV-502 (1.0% azithromycin and 0.1% dexamethasone combined) + Azasite + Dexamethasone | Sun Pharmaceutical | Phase 3 | Completed | 40 |
| TP-03 + TP-03 Vehicle | Tarsus Pharmaceuticals | Phase 3 | Completed | 34 |
| TP-03, 0.25% + TP-03 Vehicle | Tarsus Pharmaceuticals | Phase 2/3 | Completed | 32 |
| Lotilaner + Vehicle Control | LianBio | Phase 3 | Completed | 30 |